BSECompany Update8h ago · 11 Nov 2026, 12:53 pm

Corrigendum to the Press Release-Interview published in the Times of India dated November 11,2026 regarding Financial Performance for the Quarter and Half Year ended September 30, 2026

Suraksha Diagnostic Ltd · 544293

✦ AI SummaryResults

Suraksha Diagnostic Ltd issued a corrigendum to correct errors in a press release regarding its financial performance for Q2 FY 2026-27. The corrections include changing the headline to 'Suraksha Diag sees over 100 Crore total income in Q2' and correcting the quarter-on-quarter net profit to ₹15 Crore.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suraksha Diagnostic Ltd - 544293 - Corrigendum To The Press Release -Interview Published In The Times Of India Dated November 11, 2026, Regarding Financial Performance For The Quarter And Half Year Ended September 30, 2026.

Attachments (1)

📄

514e3c00-0e64-4c3f-9e3a-329faf881e6a.pdf

pdf

Download →
View document text
Date: November 11, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra - Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544293 Scrip Symbol: SURAKSHA Dear Sir / Ma’am, Sub: Corrigendum to the Press Release -Interview published in The Times of India dated November 11, 2026, regarding Financial Performance for the Quarter and Half Year ended September 30, 2026. With reference to the Press Release - Interview published in The Times of India dated November 11, 2026, concerning the financial performance of the Company for the quarter and half year ended September 30, 2026, we wish to inform you that certain inadvertent errors have occurred in the said publication. Accordingly, the following corrected heading should read: A. The headline “Suraksha Diag sees over 100 Crore net profit in Q2” shall be corrected and read as “Suraksha Diag sees over 100 Crore total income in Q2”. B. Under the heading “Highlights Q2 FY 2026-27, the Quarter-on-Quarter Net Profit has been inadvertently mentioned as ₹100.5 Crore”. Accordingly, the same shall be read as “Quarter-on- Quarter Net Profit stood at ₹15 Crore for Q2 FY 2026-27”. The aforesaid corrections are being issued to clarify the actual financial performance of the Company and rectify the inadvertent errors in the publication. You are requested to kindly take the above corrigendum for your record. For Suraksha Diagnostic Limited Shreya Arora Company Secretary & Compliance Officer Membership No.: 30892 Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750